Neogen Total Non-Operating Income/Expense 2010-2024 | NEOG

Neogen total non-operating income/expense from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Neogen Annual Total Non-Operating Income/Expense
(Millions of US $)
2024 $-73
2023 $-60
2022 $2
2021 $1
2020 $5
2019 $5
2018 $3
2017 $2
2016 $-1
2015 $-1
2014 $-0
2013 $0
2012 $0
2011 $-1
2010 $0
2009 $1
Neogen Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-11-30 $-19
2024-08-31 $-18
2024-05-31 $-19
2024-02-29 $-18
2023-11-30 $-18
2023-08-31 $-17
2023-05-31 $-16
2023-02-28 $-18
2022-11-30 $-26
2022-08-31 $1
2022-05-31 $1
2022-02-28 $0
2021-11-30 $0
2021-08-31 $-0
2021-05-31 $-0
2021-02-28 $0
2020-11-30 $0
2020-08-31 $1
2020-05-31 $1
2020-02-29 $1
2019-11-30 $1
2019-08-31 $1
2019-05-31 $1
2019-02-28 $2
2018-11-30 $1
2018-08-31 $1
2018-05-31 $0
2018-02-28 $1
2017-11-30 $1
2017-08-31 $1
2017-05-31 $-0
2017-02-28 $1
2016-11-30 $-0
2016-08-31 $0
2016-05-31 $-0
2016-02-29 $0
2015-11-30 $-0
2015-08-31 $-0
2015-05-31 $-0
2015-02-28 $-1
2014-11-30 $-0
2014-08-31 $0
2014-05-31 $0
2014-02-28 $-0
2013-11-30 $0
2013-08-31 $-1
2013-05-31 $-0
2013-02-28 $0
2012-11-30 $0
2012-08-31 $0
2012-05-31 $-0
2012-02-29 $1
2011-11-30 $-0
2011-08-31 $-0
2011-05-31 $0
2011-02-28 $-0
2010-11-30 $-0
2010-08-31 $-0
2010-05-31 $0
2010-02-28 $0
2009-11-30 $-0
2009-08-31 $0
2009-05-31 $0
2009-02-28 $1
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.315B $0.924B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $222.392B 27.46
Boston Scientific (BSX) United States $154.781B 41.84
Stryker (SYK) United States $150.988B 32.49
EssilorLuxottica (ESLOY) France $128.761B 0.00
Medtronic (MDT) Ireland $116.457B 17.30
Lonza Group Ag (LZAGY) Switzerland $48.724B 0.00
Haleon (HLN) United Kingdom $43.049B 27.97
Agilent Technologies (A) United States $42.120B 27.91
GE HealthCare Technologies (GEHC) United States $40.456B 20.98
ResMed (RMD) United States $34.834B 26.83
Terumo (TRUMY) Japan $27.701B 39.39
Koninklijke Philips (PHG) Netherlands $25.801B 19.75
Zimmer Biomet Holdings (ZBH) United States $20.443B 12.84
Insulet (PODD) United States $20.179B 80.36
Baxter (BAX) United States $15.731B 10.24
Smith & Nephew SNATS (SNN) United Kingdom $11.039B 0.00
Sunny Optical Technology (SNPTF) China $9.976B 0.00
BellRing Brands (BRBR) United States $9.951B 37.15
Bio-Rad Laboratories (BIO) United States $9.670B 32.87
Demant (WILYY) Denmark $7.946B 0.00
Lantheus Holdings (LNTH) United States $6.320B 14.69
Prestige Consumer Healthcare (PBH) United States $4.316B 20.65
ICU Medical (ICUI) United States $3.878B 36.92
Envista Holdings (NVST) United States $3.750B 29.85
Perrigo (PRGO) Ireland $3.407B 10.03
Haemonetics (HAE) United States $3.164B 14.89
GN Store Nord (GNNDY) Denmark $3.123B 21.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.832B 18.23
LeMaitre Vascular (LMAT) United States $2.245B 54.55
AtriCure (ATRC) United States $1.997B 0.00
Green Thumb Industries (GTBIF) United States $1.513B 26.48
AdaptHealth (AHCO) United States $1.300B 9.29
InMode (INMD) Israel $1.269B 10.61
Maravai LifeSciences Holdings (MRVI) United States $1.250B 0.00
BioLife Solutions (BLFS) United States $1.215B 0.00
Curaleaf Holdings (CURLF) Canada $1.069B 0.00
Phibro Animal Health (PAHC) United States $0.996B 15.27
Evolus (EOLS) United States $0.849B 0.00
CeriBell (CBLL) United States $0.810B 0.00
Owens & Minor (OMI) United States $0.667B 5.21
Capricor Therapeutics (CAPR) United States $0.652B 0.00
VAREX IMAGING (VREX) United States $0.627B 27.14
Valneva SE (VALN) France $0.563B 0.00
Omeros (OMER) United States $0.526B 0.00
SNDL (SNDL) Canada $0.507B 0.00
Surmodics (SRDX) United States $0.487B 0.00
Cresco Labs (CRLBF) United States $0.474B 0.00
Verano Holdings (VRNOF) United States $0.424B 0.00
ZimVie (ZIMV) United States $0.383B 32.26
Canopy Growth (CGC) Canada $0.363B 0.00
Aurora Cannabis (ACB) Canada $0.343B 62.50
Cerus (CERS) United States $0.323B 0.00
Quanterix (QTRX) United States $0.320B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.11
Sanara MedTech (SMTI) United States $0.309B 0.00
OraSure Technologies (OSUR) United States $0.292B 19.55
Biote (BTMD) United States $0.261B 5.73
Zynex (ZYXI) United States $0.252B 52.80
High Tide (HITI) Canada $0.238B 0.00
Sanuwave Health (SNWV) United States $0.232B 3.26
SEMPERIT AG HLD (SEIGY) Austria $0.226B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
TerrAscend (TSNDF) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.203B 15.16
Brainsway (BWAY) Israel $0.200B 106.40
MacroGenics (MGNX) United States $0.174B 0.00
TriSalus Life Sciences (TLSI) United States $0.164B 0.00
FitLife Brands (FTLF) United States $0.142B 17.83
Jin Medical (ZJYL) China $0.130B 0.00
Quipt Home Medical (QIPT) United States $0.127B 0.00
Fonar (FONR) United States $0.101B 11.44
Exagen (XGN) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.085B 0.00
InterCure (INCR) Israel $0.080B 0.00
Jushi Holdings (JUSHF) United States $0.073B 0.00
INLIF (INLF) $0.067B 0.00
Rockwell Medical (RMTI) United States $0.064B 33.00
Cytosorbents (CTSO) United States $0.057B 0.00
Ayr Wellness (AYRWF) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
MariMed (MRMD) United States $0.051B 0.00
United-Guardian (UG) United States $0.051B 14.60
Modular Medical (MODD) United States $0.048B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.035B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Nephros (NEPH) United States $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00